NCT03849534

Brief Summary

Children and adolescents are treated with routine treatment approaches for adults and one of the most commonly used treatments are occlusal appliances. The use of occlusal appliances in managing orofacial pain conditions is supported by evidence, but only for adults. However, the efficacy of the treatment approaches and any possible side-effects/impairment of mandibular growth are absent. Therefore, the aim of this project is to investigate the effectiveness and possible side-effects of different treatment modalities, such as an occlusal appliance, jaw exercises, NSAID for the conditions myalgia orarthralgia in the orofacial region in children with primary or mixed dentition.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
33mo left

Started Sep 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress39%
Sep 2024Dec 2028

First Submitted

Initial submission to the registry

February 20, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 21, 2019

Completed
5.5 years until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

March 5, 2025

Status Verified

March 1, 2025

Enrollment Period

4.3 years

First QC Date

February 20, 2019

Last Update Submit

March 3, 2025

Conditions

Keywords

ChildrenMixed dentitionPrimary dentitionAdolescentsMyalgiaArthralgia of TMJTreatmentSide-effects

Outcome Measures

Primary Outcomes (2)

  • Responders to treatment - median weekly pain intensity

    30% decrease in median weekly pain intensity using a numeric rating scale 0-10 rating the worst pain daily

    1-6 months

  • Responders to treatment - Patients global impression change scale

    The patients global impression change scale (PGIC) will be used. PGIC is a 7-point scale with the following options: 0 = eliminated, 1 = much improved, 2 = improved, 3 = unchanged, 4 = impaired, 5 = much impaired and 6 = very much impaired

    1-6 months

Secondary Outcomes (3)

  • Change in physical functioning using the Graded Chronic Painscale (GCPS)

    1-6 months

  • Change in emotional status

    1-6 months

  • Daily activities

    1-6 months

Study Arms (3)

Soft occlusal appliance

ACTIVE COMPARATOR

Individually casted appliances

Device: Soft occlusal applianceBehavioral: Jaw exercisesBehavioral: Counseling

Jaw exercises

ACTIVE COMPARATOR

Resistance exercises to do twice a day

Device: Soft occlusal applianceBehavioral: Jaw exercisesBehavioral: Counseling

Counseling

ACTIVE COMPARATOR

Just information at the first visit

Device: Soft occlusal applianceBehavioral: Jaw exercisesBehavioral: Counseling

Interventions

According to Best Practice in Sweden the soft occlusal appliance is ranked as gold standard for children with mixed or primary dentition

CounselingJaw exercisesSoft occlusal appliance
Jaw exercisesBEHAVIORAL

The participants do three exercises twice a day. Open and closing mouth against resistance as well as stretch

CounselingJaw exercisesSoft occlusal appliance
CounselingBEHAVIORAL

The patients are instructed to minimize jaw parafunctions, chewing chewing gum etc, to do exercises, to take pain-killers or NSAIDs etc.

CounselingJaw exercisesSoft occlusal appliance

Eligibility Criteria

Age7 Years - 13 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • age 7-14 years
  • a diagnosis of myalgia or arthralgia according to DC/TMD
  • self-assessed average TMD pain intensity of ≥ 30 mm on a 100-mm visual analogue scale (VAS) during one week prior to examination.
  • The patients will remain included with one or several co-diagnoses of:
  • disc displacement with or without reduction according to DC/TMD
  • degenerative joint disease.

You may not qualify if:

  • diagnosed systemic muscular or joint diseases (e.g. fibromyalgia, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis)
  • whiplash associated disorder (WAD)
  • neuropathic pain or neurological disorders (e.g. myasthenia gravis, orofacial dystonia)
  • history of psychiatric disorders, and 5) pain of dental origin.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska Institutet, Department of Dental Medicine

Huddinge, 141 04, Sweden

RECRUITING

MeSH Terms

Conditions

Temporomandibular Joint DisordersMyalgia

Interventions

Counseling

Condition Hierarchy (Ancestors)

Craniomandibular DisordersMandibular DiseasesJaw DiseasesMusculoskeletal DiseasesJoint DiseasesMuscular DiseasesStomatognathic DiseasesNeuromuscular DiseasesNervous System DiseasesMusculoskeletal PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Mental Health ServicesBehavioral Disciplines and ActivitiesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Nikolaos Christidis, PhD

    Karolinska Institutet, Department of Dental Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nikolaos Christidis, PhD

CONTACT

Sofia Louca Jounger, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
The investigator is blinded to treatment that is performed by a specialist in orofacial pain. The patient is instructed to not reveal the treatment to the investigator
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Non-inferiority study with two patient arms that are randomized to one of three different treatment arms. 75 children with TMD myalgia are randomized to one of three treatment arms 75 children with TMD arthralgia are randomized to one of three treatment arms
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor, Senior Lecturer, Senior Consultant

Study Record Dates

First Submitted

February 20, 2019

First Posted

February 21, 2019

Study Start

September 1, 2024

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

December 31, 2028

Last Updated

March 5, 2025

Record last verified: 2025-03

Locations